Clinical meaning
Disseminated intravascular coagulation (DIC) is a life-threatening acquired syndrome characterized by the paradoxical simultaneous activation of widespread intravascular coagulation and secondary fibrinolysis, resulting in microvascular thrombosis causing end-organ ischemia alongside consumption of clotting factors and platelets producing hemorrhage. DIC is never a primary diagnosis but always occurs secondary to an underlying trigger condition, most commonly sepsis (35-40% of cases), malignancy (particularly acute promyelocytic leukemia, pancreatic adenocarcinoma, and mucin-secreting tumors), obstetric catastrophes (placental abruption, amniotic fluid embolism, retained dead fetus, pre-eclampsia/HELLP syndrome), massive trauma with tissue destruction, and severe hemolytic transfusion reactions. Understanding the dual pathophysiology of clotting and bleeding occurring simultaneously is essential for nurses managing these critically ill patients. The coagulation cascade is normally maintained in a tightly regulated equilibrium between procoagulant factors, natural anticoagulant mechanisms (antithrombin III, protein C/protein S system, tissue factor pathway inhibitor), and the fibrinolytic system. In DIC, this balance is catastrophically disrupted through three interconnected pathophysiological mechanisms. The first mechanism is massive, uncontrolled activation of the tissue factor (TF) pathway. In sepsis, bacterial endotoxins (lipopolysaccharide from gram-negative organisms) and inflammatory cytokines (tumor necrosis factor-alpha,...